Table 4.

Hospital course and outcome during follow-up period

	All patients (n=24)	Immune DAH (n=11)	Nonimmune DAH (n=13)	P
Hospital length of stay, days	24,1±17,5	29,5±20,0	19,5±14,3	0,047
ICU admission	6 (25,0)	5 (45,5)	1 (7,7)	0,043
Shock	3 (12,5)	3 (27,3)	0 (0)	0,049
Invasive machanical ventilation	2 (8,3)	2 (18,2)	0 (0)	0,199
Noninvasive mechanical ventilation	2 (8,3)	2 (18,2)	0 (0)	0,199
Hemodialysis	3 (12,5)	2 (18,2)	1 (7,7)	0,576
Blood transfusion	6 (25,0)	5 (45,5)	1 (7,7)	0,043
In-hospital mortality	3 (12,5)	3 (27,3)	0 (0)	0,049
Relapse of DAH	1 (4,2)	1 (9,1)	0 (0)	0,381
Mortality during follow-up	2 (8,3)	1 (9,1)	1 (7,7)	1,000